MarketPeel
Insider Trading Intelligence
Pricing
…
MG

Michael David Garrison

BDX
EVP & PRES MED.ESSNTL&BIOPHARM · BECTON DICKINSON & CO · CIK 0001944816
FILING MIX · LIFETIME35%/65%
BUYS
13
SELLS
24
TOTAL VALUE
$5.81M
COMPANIES
1
ACTIVE SINCE
Nov 2022
HOLDINGS NOW
13,172
AVG SELL PX
$203.57
TRADE KIND
SHOWING 37 / 37
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 15 pending
Forward-return performance of every backtestable P/S trade by Michael David Garrison, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+36.36%+0.73%+0.88%-0.15%-0.64%—
14d11+63.64%-0.53%+0.35%-0.88%-0.45%—
30d11+36.36%+1.24%+1.73%-0.49%+3.00%—
60d11+45.45%-0.20%+2.44%-2.64%-1.05%—
90d11+45.45%-2.49%+2.60%-5.09%-4.94%—
180d11(2 pending)+55.56%-4.04%+11.53%-15.57%-15.26%—
1y11(5 pending)+100.00%-9.21%+19.70%-28.91%-28.53%—
2y11(8 pending)+100.00%-19.39%+47.00%-66.39%-63.48%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BDX · 13,172 shares · as of Jun 24, 2026
04,0408,08012,11916,1592023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 13 buys / 24 sellsCOVERAGE · 15 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
1,100$145.66$160.2K13,172Jun 24, 2026Jun 25, 2026 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
1,100$151.48$166.6K14,272Jun 10, 2026Jun 11, 2026 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASE
EVP & Pres Med.Essntl&BioPharm
3,054$167.91$512.8K16,159Jan 15, 2026Jan 16, 2026 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & Pres Med.Essntl&BioPharm
3,054——0Jan 15, 2026Jan 16, 2026 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & Pres Med.Essntl&BioPharm
2,454$209.00$512.9K13,705Jan 15, 2026Jan 16, 2026 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
1,010$206.54$208.6K12,095Jan 15, 2026Jan 16, 2026 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
600$209.00$125.4K13,105Jan 15, 2026Jan 16, 2026 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
629$196.03$123.3K13,105Dec 17, 2025Dec 17, 2025 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
7,568——12,455Nov 26, 2025Dec 1, 2025 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
3,048——15,503Nov 26, 2025Dec 1, 2025 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & Pres Med.Essntl&BioPharm
1,769——13,734Nov 26, 2025Dec 1, 2025 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
1,184$180.29$213.5K4,888Jul 18, 2025Jul 22, 2025 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASE
EVP & President, Medical
6,360$147.68$939.2K11,247Jul 18, 2025Jul 22, 2025 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & President, Medical
5,175$180.29$933.0K6,072Jul 18, 2025Jul 22, 2025 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
1$181.50$1824,887Jul 18, 2025Jul 22, 2025 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & President, Medical
6,360——0Jul 18, 2025Jul 22, 2025 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
479$197.28$94.5K4,887Apr 9, 2025Apr 10, 2025 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & President Medical
178——5,366Mar 1, 2025Mar 4, 2025 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
597$236.51$141.2K5,544Jan 17, 2025Jan 21, 2025 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
2,838$223.33$633.8K6,141Dec 19, 2024Dec 19, 2024 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
2,553——7,934Nov 26, 2024Nov 29, 2024 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
10,004——10,004Nov 26, 2024Nov 29, 2024 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & President, Medical
1,230——8,979Nov 26, 2024Nov 29, 2024 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
2,275——10,209Nov 26, 2024Nov 29, 2024 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
1,715$232.81$399.3K5,381Apr 30, 2024May 1, 2024 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & President Medical
178——7,096Mar 1, 2024Mar 5, 2024 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
1,239$232.46$288.0K7,274Dec 11, 2023Dec 12, 2023 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & President Medical
1,646——8,513Nov 26, 2023Nov 28, 2023 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
10,364——10,364Nov 26, 2023Nov 28, 2023 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
1,871——7,028Nov 26, 2023Nov 28, 2023 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
3,131——10,159Nov 26, 2023Nov 28, 2023 ↗View →
BDX
BECTON DICKINSON & CO
SALE10b5-1
10b5-1 plan
1,300$277.13$360.3K5,157Aug 8, 2023Aug 9, 2023 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & President Medical
193——6,457Mar 1, 2023Mar 3, 2023 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
1,223——7,267Nov 26, 2022Nov 29, 2022 ↗View →
BDX
BECTON DICKINSON & CO
SALE
EVP & President Medical
617——6,650Nov 26, 2022Nov 29, 2022 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
1,567——6,044Nov 26, 2022Nov 29, 2022 ↗View →
BDX
BECTON DICKINSON & CO
PURCHASEGRANT
Stock grant
9,466——9,466Nov 26, 2022Nov 29, 2022 ↗View →
Other insiders · BDX
Loading peer insiders…
About this filer
CIK 0001944816
ROLE
EVP & Pres Med.Essntl&BioPharm
PRIMARY
BDX
COMPANIES
1
ACTIVE SINCE
Nov 2022
MARKETPEEL · /INSIDER/0001944816DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback